Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Leukemia, Myeloid, Date of authorisatio...
Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Leukemia, Myeloid, Date of authorisation: 27/03/2013, Revision: 22, Status: Authorised Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Leukemia, Myeloid, Date of authorisation: 27/03/2013, Revision: 22, Status: Authorised Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Sleep Initiation and Maintenance Disorders, Date of authorisation: 29/04/2022, Status: Authorised Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Sleep Initiation and Maintenance Disorders, Date of authorisation: 29/04/2022, Status: Authorised Symposium Familie- en Betrokkenenraad (FBR) Ervaringen delen kan helen De FBR bestaat 10 jaar en organiseert d...